Differences in Administration of Methotrexate and Impact on Outcome in Low-Risk Gestational Trophoblastic Neoplasia

SIMPLE SUMMARY: Low-risk gestational trophoblastic neoplasia is a rare but highly curable malignancy. The most common first line treatment is methotrexate, which can be administered in different forms. In order to investigate the impact of route of administration on methotrexate resistance, toxicity...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallin, Emelie, Niemann, Isa, Faaborg, Louise, Fokdal, Lars, Joneborg, Ulrika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834333/
https://www.ncbi.nlm.nih.gov/pubmed/35159119
http://dx.doi.org/10.3390/cancers14030852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834333/
https://www.ncbi.nlm.nih.gov/pubmed/35159119
http://dx.doi.org/10.3390/cancers14030852

Ejemplares similares